TrialThe Canadian journal of cardiology2009

Economic evaluation of high-dose (80 mg/day) atorvastatin treatment compared with standard-dose (20 mg/day to 40 mg/day) simvastatin treatment in Canada based on the Incremental Decrease in End-Points Through Aggressive Lipid-Lowering (IDEAL) trial.

M Wagner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.